Quote | Imv Inc. (TSXC:IMV:CC)
Last: | $0.63 |
---|---|
Change Percent: | 1.61% |
Open: | $0.62 |
Close: | $0.62 |
High: | $0.64 |
Low: | $0.6 |
Volume: | 19,616 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Imv Inc. (TSXC:IMV:CC)
IMV Inc. (the “ Company ” or “ IMV ”) announces today that it has accepted an offer (the “ Offer ”) from IMV’s largest secured creditors (the “ Secured Lenders ”), pursuant to which IMV and its subsidiary, Immunovaccin...
IMV Inc. (the “ Company ” or “ IMV ”), recently announced an update on the Sales and Investment Solicitation Process (the “ SISP ”) implemented as part of its ongoing proceedings under the Companies' Creditors Arrangement Act (the “...
Message Board Posts | Imv Inc. (TSXC:IMV:CC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Imv Inc. Company Name:
IMV:CC Stock Symbol:
TSXC Market:
IMV Inc. (the “ Company ” or “ IMV ”) announces today that it has accepted an offer (the “ Offer ”) from IMV’s largest secured creditors (the “ Secured Lenders ”), pursuant to which IMV and its subsidiary, Immunovaccin...
IMV Inc. (the “ Company ” or “ IMV ”), recently announced an update on the Sales and Investment Solicitation Process (the “ SISP ”) implemented as part of its ongoing proceedings under the Companies' Creditors Arrangement Act (the “...
IMV Inc. (the “ Company ” or “ IMV ”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX ® platform to treat solid and hematologic cancers, today announced tha...